
Surmodics SRDX
Quartalsbericht 2025-Q2
hinzugefügt 08.08.2025
Surmodics DSO 2011-2026 | SRDX
DSO Jährlich Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.9 | 29.3 | 35.8 | 29.2 | 32.1 | 64.8 | 45 | 39 | 38.7 | 44.1 | 30.2 | 34.7 | 35.6 | 41.4 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 64.8 | 29.2 | 38.2 |
DSO Vierteljährlich Surmodics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.2 | 39.2 | 39.4 | - | 38.7 | 36 | 35.5 | - | 20.8 | 37.2 | 37.5 | - | 20.3 | 33.3 | 34.1 | - | 34 | 22.5 | 32.2 | 31.1 | 26.1 | 31.4 | 33.6 | 26.6 | 33.7 | 37.7 | 38.2 | 35.2 | 36.4 | 37.3 | 37.3 | 32.8 | 37 | 36.8 | 34.4 | 34.5 | 31.4 | 31.8 | 35.9 | 39.3 | 42.9 | 32.9 | 29.5 | 28.3 | 29.7 | 33.1 | 34.3 | 35.1 | 34.9 | 32.5 | 31.2 | 32.4 | 32.4 | 32.4 | 30.1 | 28.8 | 30.8 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 42.9 | 20.3 | 33.4 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 19.72 | 2.71 % | $ 572 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.36 | 2.57 % | $ 495 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 114.94 | 1.22 % | $ 9.48 B | ||
|
Agilent Technologies
A
|
63.8 | $ 113.33 | 2.5 % | $ 34.5 B | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.8 | - | $ 7.96 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 2.31 | 17.26 % | $ 3.07 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Illumina
ILMN
|
61.3 | $ 141.35 | -0.24 % | $ 22.5 B | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
46.1 | $ 113.24 | 15.33 % | $ 14.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.1 | 2.78 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 96.33 | 3.7 % | $ 6.5 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 421.05 | 0.27 % | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 082.63 | 3.03 % | $ 22.3 B | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.2 | 2.4 % | $ 430 M | ||
|
Natera
NTRA
|
81.5 | $ 202.96 | 3.53 % | $ 20 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 156.38 | 2.59 % | $ 7.75 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
63.8 | $ 7.86 | 11.58 % | $ 701 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.79 | 4.77 % | $ 1.13 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 3.74 | 5.21 % | $ 346 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 449.72 | 0.43 % | $ 170 B | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 5.69 | 2.62 % | $ 237 M | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 54.25 | 9.6 % | $ 3.24 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.35 | -1.26 % | $ 5.4 M | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.6 | 6.65 % | $ 216 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 257.11 | 1.35 % | $ 21.4 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
306 | $ 341.81 | 2.57 % | $ 20.4 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 8.73 | 4.49 % | $ 1.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 193.73 | 1.75 % | $ 21.5 B |